HK1055735A1 - Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts - Google Patents

Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts

Info

Publication number
HK1055735A1
HK1055735A1 HK03108049A HK03108049A HK1055735A1 HK 1055735 A1 HK1055735 A1 HK 1055735A1 HK 03108049 A HK03108049 A HK 03108049A HK 03108049 A HK03108049 A HK 03108049A HK 1055735 A1 HK1055735 A1 HK 1055735A1
Authority
HK
Hong Kong
Prior art keywords
salts
derivatives
drugs containing
imidazole
imidazole derivatives
Prior art date
Application number
HK03108049A
Other languages
English (en)
Inventor
Fujiko Konno
Yoshihiro Nagao
Kazuo Isomae
Mari Ohtsuka
Yoshiyuki Takahashi
Fumio Ishii
Niroyuki Hirota
Sunao Takeda
Noriyuki Kawamoto
Haruyoshi Honda
Susumu Sato
Original Assignee
Hisamitsu Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Medical Co Ltd filed Critical Hisamitsu Medical Co Ltd
Publication of HK1055735A1 publication Critical patent/HK1055735A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK03108049A 2000-06-28 2003-11-06 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts HK1055735A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000194024 2000-06-28
PCT/JP2001/004836 WO2002000648A1 (fr) 2000-06-28 2001-06-08 Derives imidazole ou sels de ces derniers, et medicaments contenant les derives ou les sels

Publications (1)

Publication Number Publication Date
HK1055735A1 true HK1055735A1 (en) 2004-01-21

Family

ID=18692919

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108049A HK1055735A1 (en) 2000-06-28 2003-11-06 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts

Country Status (8)

Country Link
US (1) US6958353B2 (xx)
EP (1) EP1295880A4 (xx)
KR (1) KR20030017511A (xx)
CN (1) CN1228338C (xx)
AU (1) AU2001264223A1 (xx)
CA (1) CA2410391A1 (xx)
HK (1) HK1055735A1 (xx)
WO (1) WO2002000648A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026811A1 (en) * 2003-05-20 2005-02-03 Mjalli Adnan M. M. Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
CN101597262A (zh) * 2002-03-05 2009-12-09 特兰斯泰克制药公司 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物
EP1528921A2 (en) * 2002-08-02 2005-05-11 Pharmacia Corporation Methods for treatment and prevention of gastrointestinal conditions
WO2006113704A2 (en) * 2005-04-18 2006-10-26 Neurogen Corporation Subtituted heteroaryl cb1 antagonists
TWI517850B (zh) 2009-09-30 2016-01-21 Ｖｔｖ治療有限責任公司 經取代之咪唑衍生物及其使用方法
TW201613878A (en) * 2014-07-09 2016-04-16 Janssen Pharmaceutica Nv Pyrazine GPR40 agonists for the treatment of type II diabetes
KR20200090747A (ko) 2017-09-12 2020-07-29 에이전시 포 사이언스, 테크놀로지 앤드 리서치 이소프레닐시스테인 카복실 메틸트랜스퍼라제의 억제제로 유용한 화합물
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755526A (en) 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase
NZ224714A (en) 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
CZ141795A3 (en) 1992-12-02 1995-11-15 Pfizer 4-substituted catechol diethers as such and for treating diseases and pharmaceutical preparations based thereon
JPH0733752A (ja) 1993-07-16 1995-02-03 Sankyo Co Ltd ジフェニルピラジン誘導体及び除草剤
JPH07126256A (ja) 1993-10-28 1995-05-16 Sankyo Co Ltd ジフェニルピラジン誘導体および除草剤
CA2189068A1 (en) * 1994-04-27 1995-11-02 Nobuo Mochizuki Imidazole derivative and process for producing the same
DE19541146A1 (de) * 1995-10-25 1997-04-30 Schering Ag Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
AU7674796A (en) * 1995-11-13 1997-06-05 Eli Lilly And Company Method for treating anxiety
US6297239B1 (en) * 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
JPH11158156A (ja) * 1997-12-03 1999-06-15 Earth Chem Corp Ltd 新規な１−（４−アルキルオキシフェニル）イミダゾール化合物
SE9904045D0 (sv) * 1999-11-09 1999-11-09 Astra Ab Compounds

Also Published As

Publication number Publication date
EP1295880A4 (en) 2004-05-06
CN1228338C (zh) 2005-11-23
EP1295880A1 (en) 2003-03-26
KR20030017511A (ko) 2003-03-03
WO2002000648A1 (fr) 2002-01-03
US6958353B2 (en) 2005-10-25
US20030207896A1 (en) 2003-11-06
AU2001264223A1 (en) 2002-01-08
CN1432013A (zh) 2003-07-23
CA2410391A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
HK1082249A1 (en) Isoquinoline derivatives having kinasae inhibitoryactivity and drugs containing the same
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
EP1216980A4 (en) CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
EP1306387A4 (en) MEDICAMENTS AND COSMETICS
HUP0301230A3 (en) Phenylpyridazine derivatives and drugs containing the same
HUP0101333A3 (en) Diazepan derivatives and their salts, pharmaceutical compositions containing the same
IL157908A0 (en) Phthalazinone derivatives and pharmaceutical compositions containing the same
AU2001269474A1 (en) Phenylpyridazine Compounds and Medicines Containing the Same
IL155937A0 (en) Imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same
HK1043791A1 (en) Imidazole compounds and medicinal use thereof.
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL155736A0 (en) Pyrimidine derivatives and herbicides containing the same
EG23858A (en) Drug combination
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
HUP0200088A3 (en) Pyridazin-3-one derivatives and pharmaceutical compositions containing the same
AU6475100A (en) Novel anilide derivatives or salts thereof and drugs containing the same
HK1055735A1 (en) Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
PL349133A1 (en) Benzamide derivatives and drugs containing the same

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: FROM SSP CO., LTD. ? SS?????? TO BIOMEDIX CO., LTD

CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100608